Profile picture

Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)
Membership: FESC Member
Follow
Biography
Renato D. Lopes, MD, MHS, PhD is a Professor of Medicine of the Department of Medicine of the Division of Cardiology at Duke University Medical Center, in Durham, North Carolina, USA. He completed his clinical training at the Federal University of Sao Paulo, Sao Paulo, Brazil and his Cardiology Fellowship at the Duke Clinical Research Institute (DCRI), serving as Chief Fellow for the research training program during his senior year. He is currently the Director of Clinical Events Classification (CEC) and the Co-Director of the Integrated Clinical Events-Safety Surveillance Group at the DCRI. Dr. Lopes has an interest in novel antithrombotic therapies for the management of patients with atrial fibrillation and acute coronary syndromes as well as in the discovery of new biomarkers in the field of Cardiology. Dr. Lopes has led several national and international clinical trials and registries. He has also participated in clinical events committees (CEC) for many important clinical trial.
Logo ESC

Contributor content

Innovating for neglected populations: insights from the PARACHUTE-HF Trial in Chagas heart failure
Session
Innovating for neglected populations: insights from the PARACHUTE-HF Trial in Chagas heart failure
31 August 2025
Ask the Trialists - AQUATIC
Session
Ask the Trialists - AQUATIC
31 August 2025
Ask the Trialists from Hot Lines 6 and 7
Session
Ask the Trialists from Hot Lines 6 and 7
28 August 2023
Meet the Trialist - INVICTUS
Session
Meet the Trialist - INVICTUS
28 August 2022
COVID-19 and cardiovascular pharmacotherapy
Session
COVID-19 and cardiovascular pharmacotherapy
29 August 2021
Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)
Session
Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)
3 September 2019
Atrial fibrillation patients who develop acute coronary syndrome: is there a role for aspirin?
Session
Atrial fibrillation patients who develop acute coronary syndrome: is there a role for aspirin?
27 August 2018
Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis
Session
Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis
4 March 2018

ESC 365 is supported by